Heterobicylic inhibitors of HCV

Details for Australian Patent Application No. 2006226322 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Lenz, Oliver; Lin, Tse-I; Surleraux, Dominique Louis Nestor Ghislain; Simmen, Kenneth Alan; Hart, Barry; Chakravarty, Sarvajit; Raboisson, Pierre Jean-Marie Bernard

Agent Shelston IP

Pub. Number AU-B-2006226322

PCT Pub. Number WO2006/100310

Priority 60/665,151 25.03.05 US; 60/680,405 12.05.05 US

Filing date 27 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 29 March 2012

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/100310 Priority application(s): WO2006/100310

29 March 2012 Application Accepted

  Published as AU-B-2006226322

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226334-Heat accumulation segment

2006226304-Process for microbial production of a valuable compound